Overall, our data suggest that therapeutic strategies aimed at enhancing ABCB8 function or modulating iron-dependent TGF-β signalling could hold promise for mitigating vascular inflammation and atherosclerosis. The gene discussed is ABCB8; the disease is atherosclerosis.